ACA
EBS icon

Avoro Capital Advisors’s Emergent Biosolutions EBS Stock Holding History

Avoro Capital Advisors’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-330,635
Closed -$9.51M – 33
2015
Q1 		$9.51M Hold
330,635
– – 3.65% 8
2014
Q4 		$9M Buy
+330,635
New +$7.88M 6.1% 7

Other funds holding EBS

Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
FMA
Fiduciary Management Associates Chicago, Illinois $1.53B AUM 4.47% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Avoro Capital Advisors's EBS Position: Q2 2015 in Review

Avoro Capital Advisors sold out of Emergent Biosolutions (EBS) in Q2 2015, closing a stake of 330,635 shares — an estimated $9.51M sold.

Avoro Capital Advisors first reported a position in EBS in Q4 2014 and held it in 2 quarters. The position peaked at $9.51M in Q1 2015. 184 funds tracked by Wall St. Rank hold EBS as of Q2 2015.

  • Avoro Capital Advisors reported no remaining Emergent Biosolutions position as of Q2 2015 after selling out during the quarter.
  • Avoro Capital Advisors sold 330,635 Emergent Biosolutions shares in Q2 2015, an estimated $9.51M.
  • Avoro Capital Advisors first reported a position in Emergent Biosolutions in Q4 2014 and held it in 2 quarters.
  • Avoro Capital Advisors's Emergent Biosolutions position peaked at $9.51M in Q1 2015.
  • 184 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2015.

Based on Avoro Capital Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.